{"symbol": "TROV", "companyName": "TrovaGene Inc.", "exchange": "NASDAQ Capital Market", "industry": "Medical Diagnostics & Research", "website": "http://www.trovagene.com", "description": "TrovaGene Inc is clinical-stage, precision medicine oncology therapeutics company. Its focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its Precision Cancer Monitoring technology.", "CEO": "Thomas H. Adams", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Diagnostics & Research", "Medical Diagnostics & Research"]}